RecruitingNCT06542653

Effect of PCI on Clinical Prognosis of Chronic Coronary Artery Occlusion


Sponsor

The First Affiliated Hospital with Nanjing Medical University

Enrollment

258 participants

Start Date

Sep 17, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

Coronary chronic total occlusions (CTOs) are considered to increase the risk of adverse clinical outcomes. The purpose of this study was to evaluate whether long-term clinical outcomes could be improved by successful percutaneous coronary intervention (PCI) over optimal medical therapy (OMT) in CTO patients.


Eligibility

Min Age: 18 YearsMax Age: 75 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called OMT and a procedure called PCI for people with coronary atheroscleroses. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 75 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREPCI

successful percutaneous coronary intervention (PCI) in Coronary chronic total occlusions (CTOs) patients

DRUGOMT

optimal medical therapy (OMT) in CTO patients, such as aspirin 1td, ACEI/ARB 1td, β blocker 1td, statin 1td.


Locations(1)

The First Affiliated Hospital with Nanjing Medical University

Nanjing, Jiangsu, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06542653


Related Trials